| ID | Name | CAS | Properties |
logPoct/wat |
| 12-262-7 |
3-Acetyl-5-benzylmercapto-1,3,4-thiadiazolidone-2-azine
|
114383-24-3 |
2 | 4.524 |
| 12-325-7 |
Methyl 5-«beta»-cholan-3-«alpha»,7-«alpha»-diol-12-one-24-oate, oxime, TMS
|
|
2 | 9.102 |
| 12-353-6 |
3.beta.,6.alpha.-Dihydroxy-5.alpha.-androstan-17-one, TMS
|
|
2 | 8.424 |
| 12-370-7 |
(E)-10-Dodecenoic acid, 9-hydroxy-12-oxo, methyl ester, PFB-oxime, OH-TMS, # 2
|
|
2 | 6.565 |
| 12-398-7 |
5«beta»-Androst-1-en-17«beta»-methyl-3«alpha»,17«alpha»-diol, TMS
|
|
2 | 7.635 |
| 12-410-2 |
1-(2-Methoxyethoxy)-2-methyl-2-propanol, (3-cyanopropyl)dimethylsilyl ether
|
|
2 | 2.953 |
| 12-444-5 |
L-Aspartic acid, N-(tert-butyldimethylsilyl)-, bis(tert-butyldimethylsilyl) ester
|
107715-96-8 |
2 | 6.437 |
| 12-449-0 |
13,14-Dihydro-15-keto-PGF2A, BO-TMS, isomer # 2
|
|
2 | 10.091 |
| 12-473-3 |
4-Butyl-1-phenyl-pyrazolidine-3,5-diol, O,O'-bis(tert-butyldimethylsilyl) ether
|
|
2 | 7.983 |
| 12-499-5 |
2-tert-Butyldimethylsilyl-3-N,N-bis(tert-butyldimethylsilyl)amino-1,2,4-triazole
|
|
2 | 6.948 |
| 12-589-5 |
Androst-1,4-dien-17«alpha»-methyl-4-chloro-17«beta»-ol-3-one, TMS
|
|
2 | 8.247 |
| 12-592-1 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-6.«alpha»,17«beta»-diol, bisTMTBS
|
|
2 | 10.734 |
| 12-624-5 |
5«alpha»-Androstane-3«beta»,15«alpha»,17«beta»-triol, TMS
|
|
2 | 8.299 |
| 12-638-0 |
7H-Pyrazolo[4,3-d]pyrimidin-7-one, 1,4-dihydro-
|
|
2 | -0.423 |
| 12-792-9 |
4-(2-[2-(2,4,6-Trichlorophenoxy)ethoxy]ethyl)morpholine
|
|
2 | 3.374 |
| 12-825-2 |
6-tert-Butyl-3-methylsulfanyl-5-trimethylsilyloxy-1,2,4-triazine
|
|
2 | 3.105 |
| 12-906-2 |
3-«beta»,7-«beta»-Dihydroxy-5-androsten-17-one, TMS
|
|
2 | 7.002 |
| 12-997-2 |
2,2,4,6,8,10-hexamethyl-4,6,8,10-tetraphenyl-[1,3,5,7,9,2,4,6,8,10]cyclopentasiloxane
|
|
2 | 4.702 |
| 13-028-6 |
3«alpha»,6«beta»,7«alpha»,12«alpha»-Tetrahydroxy-5«beta»-cholanoic acid, MeTMS
|
|
2 | 9.945 |
| 13-034-9 |
1,5-Diazobicyclo[3.2.1]octane, 8-indol-3-yl-
|
|
2 | 1.706 |
| 13-228-4 |
4,4'-Diacetyl-[2,2'-azo-1,3,4-thiadiazol-5-one]
|
116529-22-7 |
2 | 0.659 |
| 13-252-7 |
3-«beta»,6-«alpha»,7-«alpha»,12-«alpha»-Tetrahydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
2 | 9.945 |
| 13-321-0 |
1-(tert-Butyldimethylsilyl)-5-chloroindole-2-carboxylic acid, tert-butyldimethylsilyl ester
|
|
2 | 7.310 |
| 13-345-4 |
2-(2,2-Dimethylpentoxy)-3-methyl-6-(n-pentyl) pyrazine
|
116668-94-1 |
2 | 4.723 |
| 13-357-1 |
Propanoic acid, 2-[(4-aminocarbonylimidazol-5-yl)-1-triazen-1,3-diyl-], ethyl ester
|
|
2 | -0.433 |
| 13-376-0 |
[14C] GA7 di-acid 9,10-ene, methyl ester TMS ether
|
|
2 | 5.623 |
| 13-445-3 |
5«alpha»-Androstane-3«alpha»,6«beta»,17«beta»-triol, TMS
|
|
2 | 8.299 |
| 13-612-7 |
Acetamide, n-(6-chloro-5-nitro-4-oxo-3,4-dihydro-pyrimidin-2-yl)-
|
|
2 | -0.192 |
| 13-659-6 |
4-Nitro-N-(4-p-tolyl-thiazol-2-yl)-benzeneamine, N-tert.-butyldimethylsilyl-
|
|
2 | 7.170 |
| 13-715-3 |
6'-Glucosyl-gentobiose: aD-Glcp(1->6)-bDGlcp(1->6)-DGlc, oxime-TMS, isomer # 1
|
|
2 | 14.359 |
| 13-805-3 |
3«alpha»,16«alpha»-dihydroxy-5«beta»-androstan-17-one, MO-TMS, (syn,anti)
|
|
2 | 8.287 |
| 13-915-1 |
L-Histidine, N,1-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
107716-00-7 |
2 | 6.791 |
| 14-057-3 |
2,6-Diamino-4-oxo-1,3,3a,7-tetrazaindene mono-hydrochloride
|
|
2 | -1.900 |
| 14-085-2 |
5-«alpha»-Androst-9(11)-ene-3-«alpha»,17-«beta»-diol, TMS
|
|
2 | 7.389 |
| 14-103-1 |
N6-TFA-2'-Deoxyadenosine, 3'-O-TBDMS, 5'-O-TFA
|
|
2 | 4.111 |
| 14-386-8 |
Hexanedioic acid, 2-[(tert-butyldimethylsilyl)amino]-, bis(tert-butyldimethylsilyl) ester
|
|
2 | 7.217 |
| 14-467-8 |
3.beta.,19.alpha.-bis-(Trimethylsilyloxy)-20,29,30-trisnorlupane
|
|
2 | 9.912 |
| 14-471-3 |
1-Propene-1,2,3-tricarboxylic acid, tris(trimethylsilyl) ester, (E)-
|
55530-72-8 |
2 | 3.437 |
| 14-509-1 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-6.«alpha»,17«beta»-diol, bisTMS
|
|
2 | 7.325 |
| 14-578-5 |
Phosphorothioic acid, s-ester with n-[4-[(3-hydroxypropyl)amino]butyl]phthalimide
|
|
2 | 1.868 |
| 14-670-2 |
17-«beta»-Methyl-5-«beta»-androstan-3-«beta»,17-«alpha»-diol, per-TMS
|
|
2 | 7.859 |
| 14-672-0 |
Silane, dimethyl(dimethyl(2,6-dimethylnon-1-en-3-yn-5-yloxy)silyloxy)ethoxy-
|
|
2 | 4.844 |
| 14-794-5 |
tert-Butyl(dimethyl)silyl 4-(2-aminophenyl)-2-pyrrol[tert-butyl(dimethyl)silyl]aminomorpho-4-oxobutanoate
|
|
2 | 5.353 |
| 14-831-3 |
6-Bromo-5-tert-butyldimethylsilyloxy-2,3,6-trideoxy-L-threo-hexono-1,4-lactone
|
|
2 | 3.477 |
| 14-959-2 |
3«alpha»,7«beta»,17«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
2 | 12.024 |
| 15-049-1 |
5-«alpha»-Pregnan-3-«beta»,11-«beta»,20-«beta»-triol, TMS
|
|
2 | 8.935 |
| 15-062-6 |
5«alpha»-Androstan-3«alpha»,11«beta»-diol-17-one, TMS
|
|
2 | 8.424 |
| 15-132-8 |
13,14-Dihydro-15-keto-PGF1A, BO-TMS, isomer # 2
|
|
2 | 10.315 |
| 15-223-7 |
Benzenepropanoic acid, «alpha»,4-bis[(tert-butyldimethylsilyl)oxy]-, tert-butyldimethylsilyl ester
|
|
2 | 8.552 |
| 15-229-1 |
D-2-Aminobutyric acid, N-(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 4.908 |
| 15-303-8 |
1,3-Disiloxane, 1,3-diethoxy, 1,3-ethyl, 1,3-bis-(chloromethyl)
|
|
2 | 3.556 |
| 15-348-9 |
«alpha»-Ketoglutaric acid, tert-butyldimethylsilyl ether, bis(tert-butyldimethylsilyl) ester
|
|
2 | 7.379 |
| 15-371-3 |
Pregnan-17-ol, 3,20-bis[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»,20S)-
|
17562-94-6 |
2 | 7.220 |
| 15-402-8 |
17-«beta»-Methyl-5-«alpha»-androstan-3-«alpha»,17-«alpha»-diol, per-TMS
|
|
2 | 7.859 |
| 15-426-2 |
tert-Butyldimethylsilyl 2-[(tert-butyldimethylsilyl)amino]-3-(4-[(tert-butyldimethylsilyl)oxy]-3-chlorophenyl)propanoate
|
|
2 | 8.778 |
| 15-482-0 |
Methyl 3-«beta»,7-«alpha»,12-«alpha»-trihydroxy-5-«beta»cholanoate, TMS
|
|
2 | 9.115 |
| 15-653-0 |
9-Dodecyn-1-ol, dimethyl(dimethyl(dimethyl(pyrid-2-ylmethoxy)silyloxy)silyloxy)silyl ether
|
|
2 | 6.897 |
| 15-658-5 |
5-Pregnane-11-one-3«alpha»,20«alpha»-diol, MO-TMS
|
|
2 | 7.718 |
| 15-726-9 |
3-Deoxy-2-C-hydroxymethyl-threo-pentonic acid, pentakis-TMS
|
|
2 | 6.268 |
| 15-894-3 |
3,5-Dideoxy-threo-pentonic acid, 1,4-lactone, TMS
|
|
2 | 1.542 |
| 16-044-5 |
2-(4-Allyl-2,6-dimethoxy-phenoxy)-1 -benzo[1,3]dioxol-5-yl-propan-1-ol, TES
|
|
2 | 6.355 |
| 16-265-0 |
13,14-Dihydro-15-keto-PGE2, BO-TMS, isomer # 3
|
|
2 | 10.043 |
| 16-315-4 |
6-Azido-5-tert-butyldimethylsilyloxy-2,3,6-trideoxy-D-erythro-hexono-1,4-lactone
|
|
2 | 3.393 |
| 16-354-1 |
1H-pyrazolo[3,4-d]pyrimidine, 4-amino-1-methyl-
|
|
2 | -0.054 |
| 16-373-0 |
5«beta»-Pregnan-3«alpha»,11«beta»,17«alpha»,21-tetrol-20-one, MO-TMS (11-OH)
|
|
2 | 7.274 |
| 16-456-8 |
5«beta»-pregnane-3«alpha»,17,20«alpha»-triol, MO-TMS
|
|
2 | 9.079 |
| 16-514-3 |
Vobassan-17-oic acid, 4-demethyl-3-oxo-, methyl ester
|
2673-40-7 |
2 | 2.138 |
| 16-658-4 |
2-Pentenoic acid, 3-methyl-2-[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
55320-09-7 |
2 | 3.900 |
| 16-777-2 |
5«alpha»-Androst-1-ene-3«alpha»,17«alpha»-diol, per-TMS
|
|
2 | 7.245 |
| 16-784-4 |
2-Bromo-2-nitro-propane-1,3-diol, bis(trimethylsilyl)- ether
|
|
2 | 3.057 |
| 16-881-6 |
Oxadiazole, 1,3,4-, 2-methylthio-5-(5-nitro-2-furyl)-
|
98273-49-5 |
2 | 1.960 |
| 16-893-3 |
Glycine, N-[«alpha»-[(tert-butyldimethylsilyl)oxy]benzylidene]-, tert-butyldimethylsilyl ester
|
|
2 | 6.003 |
| 16-999-6 |
[(3S,4r,5s)-4-acetyloxy-5-(acetyloxymethyl)-2-(2,6-diaminopurin-9-yl)oxolan-3-yl] acetate
|
|
2 | -0.685 |
| 17-041-7 |
Adenosine, 2'-deoxy-N-(trimethylsilyl)-3'-O-(trimethylsilyl)-, 5'-[bis(trimethylsilyl) phosphate]
|
32645-70-8 |
2 | 6.408 |
| 17-058-9 |
(3R,4S)-3-tert-Butyldimethylsilyloxy-1-tert-butoxycarbonyl-4-hydroxyazepane
|
|
2 | 3.769 |
| 17-101-0 |
17-«alpha»-Methyl-5-«beta»-androstan-3-«beta»,17-«beta»-diol, per-TMS
|
|
2 | 7.859 |
| 17-256-9 |
5-«alpha»-Pregnan-3-«beta»,11-«beta»,20-«alpha»-triol, TMS
|
|
2 | 8.935 |
| 17-284-8 |
D-(+)-Glucuronic acid «gamma»-lactone, tris(trimethylsilyl) ether (isomer 1)
|
|
2 | 2.928 |
| 17-327-0 |
8,8'-Methylene bis-(6-chloro-3,4-dihydro-3-phenyl-2h, 1,3-benzoxazine)
|
|
2 | 7.297 |
| 17-328-9 |
Pentanedioic acid, 3-methyl-3-[(trimethylsilyl)oxy]-, bis(trimethylsilyl) ester
|
55590-95-9 |
2 | 4.133 |
| 17-381-0 |
5«beta»-Pregnan-3«alpha»,17«alpha»,21-triol-11,20-dione, MO-TMS
|
|
2 | 7.916 |
| 17-408-0 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-4.«alpha»,17«beta»-diol, bisTMIPS
|
|
2 | 9.954 |
| 17-494-5 |
3,4-Diacetyl-5-oxo-1,3,4-thiadiazolidone-2-azine
|
108952-44-9 |
2 | -1.207 |
| 17-533-1 |
5-«beta»-Pregnan-20-«beta»-ol-11-one, MO-TMS
|
|
2 | 6.888 |
| 17-534-0 |
2-(2,6-Bis(tert-butyldimethylsilyl)-3,4-2H-3-pyridyl)isoindoline-1,3-dione
|
|
2 | 6.338 |
| 17-540-3 |
5«alpha»-Androst-1-ene-3«alpha»,17«beta»-diol, per-TMS
|
|
2 | 7.245 |
| 17-645-7 |
5«beta»-Androst-1-ene-3«beta»,17«alpha»-diol, per-TMS
|
|
2 | 7.245 |
| 17-683-5 |
N-Trifluoroacetyl-O,O'-bis(trimethylsilyl)-l-dopa, trimethylsilyl ester
|
|
2 | 5.082 |
| 17-820-2 |
Benzenepropanol, 3-methoxy-4-(1-hydroxymethyl-2-(4-hydroxy-3-methoxyphenyl))ethyl, tris-TMS
|
|
2 | 7.879 |
| 17-884-2 |
13,14-Dihydro-15-keto-TxB2, BO-TMS, isomer # 2
|
|
2 | 9.817 |
| 17-953-5 |
Benzenepropanol, 3-hydroxy-4-(1-hydroxymethyl-2-(4-hydroxy-3-methoxyphenyl))ethyl, tetrakis-TMS
|
|
2 | 9.085 |
| 17-996-8 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, bis-TMS
|
|
2 | 6.326 |
| 18-051-5 |
Galactaric acid, 2,3,4,5-tetrakis-O-(trimethylsilyl)-, bis(trimethylsilyl) ester
|
56272-61-8 |
2 | 6.623 |
| 18-208-1 |
3-oxo-4,6-chol-24-oate, O-methyloxime (1)
|
|
2 | 7.138 |
| 18-247-8 |
3«alpha»,7«alpha»,12«alpha»,26-tetrahydroxy-5«beta»-cholestanoate, methyl ester-trimethylsilyl ether
|
|
2 | 10.973 |
| 18-257-7 |
d-Mannose, 2,3,4,5,6-pentakis-O-(trimethylsilyl)-, o-methyloxyme, (1E)-
|
128705-61-3 |
2 | 6.351 |
| 18-442-1 |
3,16-Bis[(trimethylsilyl)oxy]androstane, (3«beta»,5«alpha»,16«beta»)-
|
37977-24-5 |
2 | 7.469 |
| 18-455-7 |
1,2-Benzisothiazolin-3-one, 2-(0-tolylsulfonyl)-, 1,1-dioxide
|
116400-87-4 |
2 | 1.528 |
| 18-468-3 |
5-Pregnen-3-«beta»,11-«beta»,20-«beta»-triol, TMS
|
|
2 | 8.856 |
| 18-477-3 |
1H-3-benzazepine, 4-acetamido-3-acetyl-2,3-dihydro-
|
|
2 | 1.526 |
|
« Previous Results
Next Results »
|